Loading...

Loading...

Hepatitis Response Grows Ahead of Awareness Day
By Aura Moreno - Sun, 07/13/2025 - 17:01
Global and national health systems are scaling up hepatitis diagnosis and treatment as cases rise and the 2030 elimination goal draws closer.

Partnership Content

Cluster Automotriz Nuevo Leon
https://mexicobusiness.news/tag/liver-disease
More Health
Demand for Liver Disease Drugs to Surge Through 2030
By MBN Staff - Mon, 06/30/2025 - 17:28
The global liver disease treatment market is projected to reach US$69.1 billion by 2030, driven by rising cases and biotech innovation.
Mindful Drinking Rises As Awareness of Alcohol’s Effects Grows
By Sofía Garduño - Tue, 01/28/2025 - 16:34
As awareness of the negative effects of alcohol rises, more people are avoiding alcoholic beverages to improve their health.
Echosens Launches LHM Platform to Improve Liver Disease Care
By MBN Staff - Tue, 11/19/2024 - 09:12
Echosens launches the LHM platform to enhance liver disease care, enabling early detection and better patient outcomes.

Boehringer Ingelheim's Survodutide Receives FDA Approval
By MBN Staff - Tue, 10/15/2024 - 10:07
Boehringer Ingelheim's survodutide gains FDA Breakthrough Therapy designation for MASH, advancing treatment options.

FDA Approves Gilead's Livdelzi for Liver Disease PBC
By MBN Staff - Fri, 08/16/2024 - 16:58
The FDA approves Gilead's Livdelzi for PBC, a key addition to liver disease treatments, with projected peak sales of US$847 million.
HGMEL Launches Hepatitis C Screening to Boost Early Detection
By Sofía Garduño - Wed, 07/31/2024 - 16:54
The General Hospital "Dr. Eduardo Liceaga” (HGMEL) is introducing a hepatitis C screening initiative to improve treatment and reduce complications.
FDA's 3Q24 Decisions: Key Drug Approvals to Watch
By MBN Staff - Thu, 07/25/2024 - 10:14
FDA's third-quarter decisions could reshape drug markets with potential approvals for treatments.

FDA Grants Approval to Genfit and Ipsen's Liver Drug
By MBN Staff - Tue, 06/11/2024 - 17:06
Ipsen and Genfit receive approval for Iqirvo, a new treatment for chronic liver disease, with potential benefits over existing therapies